What type of study is this?

This is a Pre-Registered Trial study.

What question did this study set out to answer?

This research evaluates the effect of primary CNS prophylaxis on high CNS-IPI DLBCL patients.

December 8, 2025Blood

View Full Paper

Ask AI

Bookmark

Authors

Analysis shows no benefit of CNS prophylaxis on progression-free survival in DLBCL patients, indicating further studies are needed.

This research evaluates the effect of primary CNS prophylaxis on high CNS-IPI DLBCL patients.
Analyzed DLBCL patients from the Czech National Lymphoma Project
Compared outcomes of patients who received CNS prophylaxis with those who did not
Utilized patient records for missing data and subgroup analysis.
5-year cumulative incidence of CNS progression was 8.8% in high CNS-IPI patients
No significant difference in progression-free survival between prophylaxis groups
No impact of timing or dosage of CNS prophylaxis on outcomes observed.

Klánová et al. (2025) studied this question.

View Full Paper

Ask AI

Bookmark